Home
Scholarly Works
Teclistamab in Relapsed or Refractory Multiple...
Journal article
Teclistamab in Relapsed or Refractory Multiple Myeloma. Reply.
Authors
Moreau P; Girgis S; Goldberg JD
Journal
N Engl J Med, Vol. 387, No. 18, pp. 1722–1723
Publication Date
November 3, 2022
DOI
10.1056/NEJMc2211969
Associated Experts
Hira Mian
Associate Professor, Faculty of Health Sciences
Visit profile
Labels
Medical Subject Headings (MeSH)
Humans
Multiple Myeloma
Neoplasm Recurrence, Local
Antineoplastic Agents
Antineoplastic Combined Chemotherapy Protocols
Antibodies, Bispecific
Fields of Research (FoR)
32 Biomedical and clinical sciences
42 Health sciences
View published work (Non-McMaster Users)
View published work (McMaster Users)
Scholarly citations from Dimensions
Contact the Experts team
Get technical help
or
Provide website feedback